What Veeda Lifesciences does

Veeda Lifesciences is a global Contract Research Organisation (CRO) headquartered in Ahmedabad, India, providing end-to-end drug development services to pharmaceutical, biotechnology, and generic drug companies. Founded in 2004 as Veeda Clinical Research and rebranded to Veeda Lifesciences in January 2025, the company operates through 2,100+ professionals across 9 countries and 26 geographies, with subsidiaries including Bioneeds for preclinical services and Veeda Europe based in Athens. Its service portfolio spans preclinical (GLP toxicology, IND-enabling studies via Bioneeds), small molecule development (bioanalytical, BA/BE studies, complex generics), large molecule / biopharma services (analytical sciences, biological sciences, bioprocess development, clinical bioanalysis), and full-service clinical trials across Phase I–IV with a specialization in hemato-oncology.

The technology stack combines in-house platforms with industry-standard tools: a Clinical Trial Management System (CTMS) and Electronic Data Capture (EDC) systems supporting integrations with Medidata Rave, Oracle Clinical, Octalsoft, and Medrio; bioanalytical platforms including LC-MS/MS, ICP-OES, ICP-MS, and SFC-MS/MS with 1.2 million-sample annual processing capacity; an AI-powered patient matching system analyzing global EMR data; a Real-World Evidence database of 2 million+ oncology patient records; and advanced microsampling methods enabling 10–20 µL sample volumes. The company reports throughput gains of 30% from automated sample processing, bioanalytical study reports in under 3 weeks, and elimination of 10,000+ paper forms annually.

Veeda generates revenue through fee-for-service professional services contracts with enterprise pharmaceutical and biotech clients, selling project-based engagements rather than recurring subscriptions. GTM is direct enterprise field sales, supported by conference presence (BIO, CPHI, ASCO, ESMO, EHA, ASH), content marketing, webinars, and case studies. The company reports a 90%+ client retention rate and is recognized by USFDA, WHO, EMA, ANVISA, MHRA, and AGES, with 23,500+ GLP regulatory submissions completed via Bioneeds. The January 2025 rebrand and July 2025 AI investment in Mango Sciences signal a strategic pivot from a generics-focused Indian CRO toward a tech-driven, innovation-oriented global CRO spanning small molecules to biologics.

Name

Veeda Lifesciences

Legal name

Veeda Clinical Research Limited

Website

https://veedalifesciences.com

Company type

Private

Operating status

Operating

Short description

Veeda Lifesciences is a global Contract Research Organisation (CRO) offering end-to-end drug development services — preclinical, bioanalytical, BA/BE, biopharma, and clinical trials Phase I–IV — to innovator pharma, generic drug, and biotech companies across 9 countries.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Drug Development Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Contract research organization
• Clinical trial services
• Bioanalytical services
• Drug development solutions
• Biopharmaceutical research

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. CRO Services (Preclinical, Clinical, Bioanalytical): Fee-for-service model providing comprehensive contract research services including preclinical studies, bioanalytical services, BA/BE studies, and clinical trials (Phase I-IV). Revenue is generated through project-based contracts with pharmaceutical companies for drug development services. The company offers both standalone services and integrated end-to-end solutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Veeda Lifesciences is a global contract research organization (CRO) providing integrated drug development services to pharmaceutical and biopharma clients. Its core offerings include clinical trial management (Phase II–IV), bioanalytical and pharmacokinetic studies, biopharmaceutical development, central laboratory/diagnostic services, clinical data management and biostatistics, site management, and real-world evidence studies. The company delivers these services across 9 countries and 26 geographies, leveraging AI/analytics-enabled platforms and a workforce of 2,100+ professionals.

Product overview

Veeda Lifesciences is a global Contract Research Organization (CRO) offering integrated, end-to-end drug development services as a unified platform spanning from discovery through market approval. The portfolio includes preclinical services (via subsidiary Bioneeds), small molecule development, biopharma/large molecule services (Veeda Biopharma), bioanalytical services, BA/BE studies, complex generics development, and full-service clinical trials across all phases. Central Services provides biometrics, regulatory affairs, project management, and medical writing support, while Real World Evidence Services enables AI-powered patient recruitment. The company operates across 9 countries with 26 geographic sites and a global team of 2,100+ professionals.

Differentiator

Problem solved

Functional benefit

Brands

• Bioneeds: Preclinical research services subsidiary offering GLP toxicology, IND-enabling studies, and regulatory compliant data. Operating as 'Bioneeds, a Veeda Lifesciences company'.

Products and services

• Clinical Trial Management (Phase II–IV)

Quantifiable outcome

• 30% throughput improvement from automated sample processing systems
• +6 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability7 records

Feature8 records

Scale indicators14 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Largest global CRO and healthcare data/analytics company. Competes across Veeda's clinical trial, RWE, and biopharma service lines but with substantially greater scale, proprietary data assets, and technology investment.
• Syneos Health: Global biopharma solutions organization spanning clinical development and commercial services. Direct overlap with Veeda's clinical trial operations and full-service offerings.
• Parexel International: Global CRO serving biopharma with clinical, regulatory, real-world evidence, and biopharma services. Direct overlap with Veeda's full-service clinical and central services portfolio.
• Labcorp Drug Development (Fortrea): Spun out from Labcorp, Fortrea operates a global CRO across clinical, bioanalytical, and central lab services. Direct overlap with Veeda's clinical trials and bioanalytical service lines.
• ICON plc: Top-3 global CRO providing clinical research, biometrics, and laboratory services. Direct competitor for Veeda's Phase I-IV and central services offerings across pharma and biotech sponsors.

Direct peers

• Syngene International: India-headquartered, publicly listed CRO offering discovery, development, and manufacturing services to global pharma. Most direct comparable by geography, scale (~5,000+ employees), and integrated service model.
• Medpace: Mid-size, science-focused global CRO with strong therapeutic-area expertise and full-service clinical offerings. Comparable mid-market positioning with similar focus on complex therapeutic areas.
• Pharmaron: China-based global CRO/CDMO with integrated drug discovery, preclinical, clinical, and biologics services. Comparable end-to-end service model and Asian-headquartered global delivery structure.
• Charles River Laboratories: Global CRO with strong preclinical/early-stage research focus (analogous to Veeda's Bioneeds subsidiary), plus biologics services. Most comparable to Veeda's preclinical and biopharma capabilities.
• WuXi AppTec: Asia-headquartered global CRO/CDMO offering preclinical, clinical, and biologics services. Comparable integrated service model and Asia-cost-base delivery structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/veedacr
• YouTubeyoutube.com/channel/UCym29qq2o9fDiAdA5QZ8Gjw
• Facebookfacebook.com/veedacr
• LinkedInlinkedin.com/company/veedacr
• Instagraminstagram.com/veeda_lifesciences?igsh=MTZxNXhvbG4xazduYg%3D%3D&utm_source=qr

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veeda Lifesciences